Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acceptance and Commitment Therapy | 3 | 2025 | 13 | 1.980 |
Why?
|
| Chronic Pain | 4 | 2025 | 156 | 1.890 |
Why?
|
| Pain Management | 4 | 2025 | 169 | 1.780 |
Why?
|
| Veterans | 11 | 2025 | 780 | 1.570 |
Why?
|
| Psychiatry | 1 | 2025 | 127 | 0.800 |
Why?
|
| Opioid-Related Disorders | 4 | 2025 | 513 | 0.460 |
Why?
|
| Self-Management | 2 | 2025 | 64 | 0.430 |
Why?
|
| Social Support | 3 | 2025 | 376 | 0.420 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 575 | 0.330 |
Why?
|
| Community Integration | 3 | 2018 | 7 | 0.320 |
Why?
|
| Adult | 13 | 2025 | 17121 | 0.250 |
Why?
|
| Opiate Substitution Treatment | 2 | 2025 | 212 | 0.240 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2025 | 555 | 0.240 |
Why?
|
| Equivalence Trials as Topic | 1 | 2025 | 14 | 0.240 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2005 | 94 | 0.230 |
Why?
|
| Humans | 23 | 2025 | 64251 | 0.230 |
Why?
|
| Acute Pain | 1 | 2025 | 21 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2020 | 402 | 0.220 |
Why?
|
| Buprenorphine | 3 | 2025 | 194 | 0.210 |
Why?
|
| Employment | 1 | 2025 | 128 | 0.210 |
Why?
|
| Pain Measurement | 1 | 2025 | 348 | 0.210 |
Why?
|
| Pilot Projects | 2 | 2024 | 1019 | 0.200 |
Why?
|
| Tobacco Use Cessation | 1 | 2022 | 29 | 0.190 |
Why?
|
| Male | 13 | 2025 | 30305 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 575 | 0.190 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 531 | 0.180 |
Why?
|
| Internet | 1 | 2025 | 467 | 0.180 |
Why?
|
| Transgender Persons | 1 | 2022 | 69 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 788 | 0.170 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2021 | 2 | 0.170 |
Why?
|
| Female | 12 | 2025 | 33360 | 0.170 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 4 | 0.170 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 78 | 0.170 |
Why?
|
| Naltrexone | 2 | 2021 | 88 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 2621 | 0.170 |
Why?
|
| Mental Disorders | 2 | 2025 | 794 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 1683 | 0.160 |
Why?
|
| Mental Health | 2 | 2023 | 372 | 0.160 |
Why?
|
| Narcotic Antagonists | 2 | 2021 | 132 | 0.160 |
Why?
|
| Middle Aged | 10 | 2025 | 17906 | 0.150 |
Why?
|
| United States | 11 | 2025 | 7923 | 0.150 |
Why?
|
| Pandemics | 1 | 2023 | 676 | 0.140 |
Why?
|
| Robotics | 1 | 2019 | 87 | 0.140 |
Why?
|
| Rehabilitation, Vocational | 1 | 2018 | 32 | 0.140 |
Why?
|
| Self-Help Groups | 1 | 2018 | 37 | 0.140 |
Why?
|
| Employment, Supported | 1 | 2018 | 21 | 0.140 |
Why?
|
| Quality of Life | 1 | 2025 | 1257 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 744 | 0.140 |
Why?
|
| Education | 1 | 2018 | 69 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2737 | 0.130 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2005 | 68 | 0.130 |
Why?
|
| Aged | 7 | 2025 | 14657 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2025 | 5691 | 0.120 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 270 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1118 | 0.110 |
Why?
|
| Ambulatory Care | 3 | 2005 | 317 | 0.110 |
Why?
|
| Methadone | 2 | 2025 | 136 | 0.090 |
Why?
|
| Veterans Health | 2 | 2024 | 157 | 0.080 |
Why?
|
| Injections, Intramuscular | 2 | 2021 | 72 | 0.080 |
Why?
|
| HIV Infections | 3 | 2005 | 976 | 0.080 |
Why?
|
| Hospitalization | 2 | 2005 | 1368 | 0.070 |
Why?
|
| Young Adult | 3 | 2022 | 4780 | 0.060 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2005 | 8 | 0.060 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2005 | 19 | 0.060 |
Why?
|
| Self-Control | 1 | 2025 | 9 | 0.060 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2025 | 88 | 0.060 |
Why?
|
| Social Stigma | 1 | 2025 | 74 | 0.060 |
Why?
|
| Health Resources | 1 | 2005 | 94 | 0.060 |
Why?
|
| Hospitals, Military | 1 | 2023 | 4 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2025 | 167 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2005 | 930 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 6732 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2021 | 8 | 0.040 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2021 | 25 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 728 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 58 | 0.040 |
Why?
|
| Confidence Intervals | 3 | 2005 | 239 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 118 | 0.040 |
Why?
|
| Caregivers | 1 | 2024 | 283 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 207 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2023 | 290 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2005 | 759 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 744 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2005 | 2604 | 0.040 |
Why?
|
| Peer Group | 1 | 2018 | 104 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2019 | 140 | 0.030 |
Why?
|
| Workplace | 1 | 2018 | 174 | 0.030 |
Why?
|
| Family | 1 | 2018 | 243 | 0.030 |
Why?
|
| Counseling | 1 | 2018 | 370 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2005 | 5527 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1118 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3316 | 0.030 |
Why?
|
| Patient Admission | 2 | 2005 | 198 | 0.030 |
Why?
|
| Length of Stay | 2 | 2005 | 818 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2005 | 53 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 138 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 251 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 69 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 289 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2005 | 136 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 214 | 0.010 |
Why?
|
| Poverty | 1 | 2005 | 299 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 202 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 788 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1270 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2005 | 711 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 5339 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 6304 | 0.010 |
Why?
|